s6y

4 Lev Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001144204-08-058740

Documents

  1. v129368_ex.html 4
  2. v129368_ex.xml 4

On sec.gov